Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PATHGEN LABORATORY

NPI: 1285383984 · CARROLLTON, TX 75006 · Clinical Medical Laboratory · NPI assigned 03/21/2022

$0.00
Total Medicaid Paid
2,707
Total Claims
1,088
Beneficiaries
32
Codes Billed
2023-11
First Month
2024-02
Last Month

Provider Details

Authorized OfficialMASRI, RIYAD (OWNER)
NPI Enumeration Date03/21/2022

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2023 690 $0.00
2024 2,017 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87581 308 105 $0.00
87640 345 118 $0.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 32 17 $0.00
82746 32 17 $0.00
86140 30 16 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 345 118 $0.00
83735 34 19 $0.00
84443 Thyroid stimulating hormone (TSH) 30 17 $0.00
84153 31 17 $0.00
87486 272 93 $0.00
86803 30 16 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 39 20 $0.00
83036 Hemoglobin; glycosylated (A1C) 35 19 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 36 20 $0.00
86704 21 12 $0.00
85652 32 17 $0.00
82607 26 14 $0.00
80053 Comprehensive metabolic panel 38 20 $0.00
86376 25 13 $0.00
86706 21 12 $0.00
81001 46 26 $0.00
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 348 119 $0.00
84481 27 14 $0.00
84403 27 13 $0.00
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 41 23 $0.00
86708 21 12 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 45 25 $0.00
87631 272 93 $0.00
84439 28 15 $0.00
80061 Lipid panel 37 20 $0.00
83540 31 16 $0.00
84100 22 12 $0.00